ANNX Latest Press Releases

-- February 17, 2026 --

Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy Globe Newswire 8:00 AM

-- January 16, 2026 --

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:05 PM

-- January 12, 2026 --

Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026 Globe Newswire 7:00 AM

-- January 8, 2026 --

Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barr Syndrome Globe Newswire 8:00 AM

-- January 7, 2026 --

Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

-- December 16, 2025 --

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:31 PM

-- November 12, 2025 --

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 10:55 PM

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:12 PM

-- November 10, 2025 --

Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software